Literature DB >> 28672162

Interaction studies of polybrominated diphenyl ethers (PBDEs) with human serum albumin (HSA): Molecular docking investigations.

Songwen Tan1, Zhenxing Chi2, Ye Shan1, Zhengzhong Wen1, Weiguo Li1.   

Abstract

This work has evaluated the interactions of HSA and typical PBDEs (BDE47, BDE99, BDE100, BDE153 and BDE209) at molecular level by modelling. Apart from the BDE209, PBDEs with higher molecular weight show higher binding energy with the residues of HSA. The BDE209 without H atoms has the lowest binding energy (-ΔGbinding: 4.30calmol-1) than other PBDEs (-ΔGbinding: 7.93-8.42calmol-1). The BDE99 shows a higher binding energy than its isomer (BDE100). On the other hand, the lgKow-depth plotting figure shows that a higher Kow value (hydrophobicity) of PBDEs is accompanied by a deeper binding site within the central channel of HSA. This work may provide a theoretical method to assess the transport and distribution of PBDEs in human body.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Binding depth; Human serum albumin; Molecule docking; Polybrominated diphenyl ethers

Mesh:

Substances:

Year:  2017        PMID: 28672162     DOI: 10.1016/j.etap.2017.06.005

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  3 in total

1.  Using Human Serum Albumin Binding Affinities as a Proactive Strategy to Affect the Pharmacodynamics and Pharmacokinetics of Preclinical Drug Candidates.

Authors:  Jianwei Fan; Katherine Gilmartin; Steven Octaviano; Francisca Villar; Brianna Remache; John Regan
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-16

2.  A Pilot Study on the Concentration, Distribution and Bioaccumulation of Polybrominated Diphenyl Ethers (PBDEs) in Tissues and Organs of Grassland Sheep.

Authors:  Wenming Chen; Xinrui Yang; Junsong Bao; Ziyi Lin; Tianwei Li; Ying Wang; Aiqin Zhang; Jicheng Hu; Jun Jin
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

3.  Effects of Shenkang Injection Combined with Jinshuibao on Early Diabetic Nephropathy and Effects on Coagulation Fibrinolysis System and Urinary Protein.

Authors:  Jianhua Zhu; Tingting Yang; Jie Luo; Mian Wei; Hanyu Li; Yue Qi; Jiali He; Min Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.